Ascendis Pharma A/S (ASND)
140.41
-0.49
(-0.35%)
USD |
NASDAQ |
Apr 19, 16:00
140.41
0.00 (0.00%)
After-Hours: 18:09
Ascendis Pharma Market Cap: 7.949B for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 7.977B |
| April 17, 2024 | 8.049B |
| April 16, 2024 | 8.011B |
| April 15, 2024 | 8.222B |
| April 12, 2024 | 8.268B |
| April 11, 2024 | 8.551B |
| April 10, 2024 | 8.638B |
| April 09, 2024 | 8.700B |
| April 08, 2024 | 8.429B |
| April 05, 2024 | 8.485B |
| April 04, 2024 | 8.359B |
| April 03, 2024 | 8.464B |
| April 02, 2024 | 8.282B |
| April 01, 2024 | 8.604B |
| March 28, 2024 | 8.558B |
| March 27, 2024 | 8.404B |
| March 26, 2024 | 8.490B |
| March 25, 2024 | 8.179B |
| March 22, 2024 | 8.210B |
| March 21, 2024 | 8.276B |
| March 20, 2024 | 8.165B |
| March 19, 2024 | 8.230B |
| March 18, 2024 | 8.326B |
| March 15, 2024 | 8.419B |
| March 14, 2024 | 8.486B |
| Date | Value |
|---|---|
| March 13, 2024 | 8.717B |
| March 12, 2024 | 8.707B |
| March 11, 2024 | 8.389B |
| March 08, 2024 | 8.301B |
| March 07, 2024 | 8.282B |
| March 06, 2024 | 8.267B |
| March 05, 2024 | 8.523B |
| March 04, 2024 | 8.378B |
| March 01, 2024 | 8.632B |
| February 29, 2024 | 8.365B |
| February 28, 2024 | 8.318B |
| February 27, 2024 | 8.794B |
| February 26, 2024 | 8.919B |
| February 23, 2024 | 9.024B |
| February 22, 2024 | 8.956B |
| February 21, 2024 | 8.896B |
| February 20, 2024 | 8.875B |
| February 16, 2024 | 8.854B |
| February 15, 2024 | 8.334B |
| February 14, 2024 | 8.300B |
| February 13, 2024 | 8.116B |
| February 12, 2024 | 8.186B |
| February 09, 2024 | 8.025B |
| February 08, 2024 | 7.884B |
| February 07, 2024 | 7.886B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.933B
Minimum
Apr 28 2023
9.762B
Maximum
Dec 14 2020
6.582B
Average
6.525B
Median
Jan 28 2020
Market Cap Benchmarks
| Evaxion Biotech AS | 22.06M |
| Genmab A/S | 18.73B |
| NuCana PLC | 8.014M |
| Autolus Therapeutics PLC | 1.197B |
| TC BioPharm (Holdings) PLC | 4.697M |
Market Cap Related Metrics
| PS Ratio | 27.41 |
| Price | 140.41 |
| Earnings Yield | -6.61% |